Annual Meeting Proxy Details Include $34M MOB Project Terms and Extensive Related-Party Disclosures
summarizeSummary
Universal Health Realty Income Trust filed its definitive proxy statement for the June 10, 2026, annual meeting, detailing proposals, executive compensation, and providing specific terms for the $34 million Palm Beach Gardens Medical Plaza I development, including related-party leases with a UHS subsidiary.
check_boxKey Events
-
Annual Shareholder Meeting Scheduled
The Annual Meeting of Shareholders will be held virtually on Wednesday, June 10, 2026, at 10:00 a.m. Eastern Time, with a record date of April 13, 2026.
-
Key Shareholder Proposals Outlined
Shareholders will vote on the election of two Class I Trustees (Alan B. Miller and Robert F. McCadden), an advisory (nonbinding) vote on named executive officer compensation, and the ratification of KPMG LLP as the independent registered public accounting firm for 2026.
-
Detailed Terms for $34M MOB Development
The filing provides specific terms for the Palm Beach Gardens Medical Plaza I, an 80,000 square foot medical office building with an estimated cost of $34 million. Construction commenced in February 2026, with a 10-year master flex lease for approximately 75% of the rentable space secured with a UHS subsidiary.
-
Extensive Related-Party Transaction Disclosure
The company details its significant related-party transactions with Universal Health Services (UHS) subsidiaries, including leases that accounted for approximately 40% of consolidated revenues for the past five years, along with renewal options and purchase rights for UHS.
auto_awesomeAnalysis
This definitive proxy statement provides shareholders with crucial details for the upcoming annual meeting, including routine proposals for trustee elections, executive compensation, and auditor ratification. Critically, it offers a comprehensive update on the previously announced $34 million Palm Beach Gardens Medical Plaza I development, detailing the ground lease and a 10-year master flex lease with a Universal Health Services (UHS) subsidiary for 75% of the space. This level of detail on a significant capital project, especially its related-party nature, is important for investors. Furthermore, the filing thoroughly outlines the company's unique advisory fee structure with UHS and the extensive related-party leases that constitute approximately 40% of UHT's consolidated revenues, providing essential context for evaluating the company's operational and financial independence.
At the time of this filing, UHT was trading at $40.86 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $566.9M. The 52-week trading range was $35.26 to $44.70. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.